- Patent Title: Composition for the prevention or treatment of obesity, dyslipidaemia, fatty liver or insulin resistance syndrome, comprising piperonal as an active ingredient
-
Application No.: US13695651Application Date: 2010-11-19
-
Publication No.: US09884041B2Publication Date: 2018-02-06
- Inventor: Tae Sun Park
- Applicant: Tae Sun Park
- Applicant Address: KR Incheon
- Assignee: YONSEI UNIVERSITY TECHNOLOGY HOLDINGS, INC.
- Current Assignee: YONSEI UNIVERSITY TECHNOLOGY HOLDINGS, INC.
- Current Assignee Address: KR Incheon
- Agency: Clark & Elbing LLP
- Agent Susan M. Michaud
- Priority: KR10-2010-0041249 20100503
- International Application: PCT/KR2010/008206 WO 20101119
- International Announcement: WO2011/139010 WO 20111110
- Main IPC: A61K31/36
- IPC: A61K31/36 ; A23L33/105

Abstract:
Provided is a composition for the prevention or treatment of obesity, dyslipidaemia, fatty liver or insulin resistance syndrome, comprising piperonal as an active ingredient. The composition of the present invention can be used to advantage as a drug or functional food composition which not only exhibits activity in the prevention or treatment of obesity, hyperlipidaemia or fatty liver but which also causes a significant reduction in fasted blood sugar and blood insulin concentration and hence has an effect in improving Type-2 diabetes or insulin resistance and also improves metabolic disorder which is closely associated therewith.
Public/Granted literature
Information query